Pamela Kunz: Disrupting GI Oncology: Shattering Barriers with Inclusive Science
Pamela Kunz, Director of the Center for Gastrointestinal Cancers at Yale Cancer Center, shared a post by ASCO on X:
”Thrilled to share that I’ll be giving the GI 2025 keynote on ‘Disrupting GI Oncology: Shattering Barriers with Inclusive Science.’
We’ll need to think collectively about inclusive science more than ever.”
Quoting ASCO‘s post:
”Discover emerging treatment modalities, novel therapies, the latest clinical trial results, advances in precision medicine, and more at the 2025 ASCO GI Cancers Symposium.”
Pamela Kunz is an Associate Professor of Medicine in the Division of Oncology at Yale School of Medicine, Director of the Center for Gastrointestinal Cancers at Yale Cancer Center and Smilow Cancer Hospital. She was formerly the director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship.
Dr. Kunz is the President of the North American Neuroendocrine Tumor Society (NANETS) and Chair of the Neuroendocrine Tumor Taskforce of the NCI. In addition, she has emerged as a leading voice for promoting gender equity in the medical workforce and has been appointed as the Vice Chief for DEI for the Section of Medical Oncology at Yale.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023